Applying AI to adverse event case processing: sharpening the impact of pharmacovigilance
20 June 2025
No Comments
For major pharma brands, for which pharmacovigilance (PV) has up to now primarily involved
Tag: PHARMACOVIGILANCE
Findings from Boehringer Ingelheim’s recent rollout of AI in Pharmacovigilance (PV)
20 June 2025
No Comments
What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable
